We are live on ! Find out more
TBRA

Tobira Therapeutics, Inc. Common Stock
TBRA

Delisted

TBRA was delisted on the 31st of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in Tobira Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 68 → 0 (-68)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $505M → $0 (-$505M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 67

Holders
–
Holders Change
-68
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
67
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$147M
2
FM
Frazier Management
Washington
-$106M
3
PC
Paulson & Co
New York
-$42.5M
4
GL
Governors Lane
New York
-$36.6M
5
Franklin Resources
Franklin Resources
California
-$29.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
TSS
51
Two Sigma Securities
New York
– -$217K -5,457 Closed
Wells Fargo
52
Wells Fargo
California
– -$210K -5,296 Closed
AIG
53
American International Group
New York
– -$203K -5,107 Closed
BA
54
BlackRock Advisors
Delaware
– -$136K -3,418 Closed
HA
55
Havens Advisors
New York
– -$119K -3,000 Closed
Credit Agricole
56
Credit Agricole
France
– -$90K -2,264 Closed
BlackRock
57
BlackRock
New York
– -$35K -875 Closed
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$24K -609 Closed
SO
59
STRS Ohio
Ohio
– -$22K -577 Closed
Bank of America
60
Bank of America
North Carolina
– -$21K -545 Closed
CG
61
Cutler Group
California
– -$11K -300 Closed
RFA
62
Reilly Financial Advisors
California
– -$12K -300 Closed
EDRH
63
Edmond de Rothschild Holding
Switzerland
– -$5K -130 Closed
AIM
64
Acrospire Investment Management
Illinois
– -$4K -105 Closed
Barclays
65
Barclays
United Kingdom
– -$2K -56 Closed
LTFS
66
Ladenburg Thalmann Financial Services
Florida
– -$2K -55 Closed
TRCT
67
Tower Research Capital (TRC)
New York
– -$2K -50 Closed
1 2
3

TBRA Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q4 2016, worth a combined $0 — down 100% from $505M a quarter earlier.

Sellers outnumbered buyers: 67 funds closed out of TBRA and 0 opened new positions — a net loss of 67 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $147M sold.

  • 0 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q4 2016, down from 68 in Q3 2016.
  • Funds reported $0 of Tobira Therapeutics, Inc. Common Stock stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q4 2016 and 67 closed out, a net change of -67 holders.
  • The largest Tobira Therapeutics, Inc. Common Stock seller in Q4 2016 was Pentwater Capital Management, an estimated $147M sold.

Based on aggregated 13F filings for Q4 2016.